Cargando…

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

BACKGROUND: Endothelial dysfunction, largely dependent on impaired nitric oxide bioavailability, has been reportedly associated with incident type 2 diabetes. Our aim was to test the hypothesis that asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide formation, might be linke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surdacki, Andrzej, Kruszelnicka, Olga, Rakowski, Tomasz, Jaźwińska-Kozuba, Aleksandra, Dubiel, Jacek S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642017/ https://www.ncbi.nlm.nih.gov/pubmed/23578341 http://dx.doi.org/10.1186/1475-2840-12-64

Ejemplares similares

Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016)

Associations between Endogenous Dimethylarginines and Renal Function in Healthy Children and Adolescents
por: JaŸwińska-Kozuba, Aleksandra, et al.
Publicado: (2012)

Coincidence of Moderately Elevated N-Terminal Pro–B-Type Natriuretic Peptide, Endothelial Progenitor Cells Deficiency and Propensity to Exercise-Induced Myocardial Ischemia in Stable Angina
por: Surdacki, Andrzej, et al.
Publicado: (2010)

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
por: Sulicka, Joanna, et al.
Publicado: (2012)

Predictors of Coronary and Carotid Atherosclerosis in Patients with Severe Degenerative Aortic Stenosis
por: Bobrowska, Beata, et al.
Publicado: (2013)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
por: Kocayiğit, İbrahim, et al.
Publicado: (2020)

Decline of popliteal artery flow-mediated dilation with aging and possible involvement of asymmetric dimethylarginine in healthy men
por: Nakamura, Akihiro, et al.
Publicado: (2019)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
por: Landim, M.B.P., et al.
Publicado: (2013)

Opposite Associations of Plasma Homoarginine and Ornithine with Arginine in Healthy Children and Adolescents
por: JaŸwińska-Kozuba, Aleksandra, et al.
Publicado: (2013)

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study
por: Chachaj, Angelika, et al.
Publicado: (2018)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Predictive Utility of NT-pro BNP for Infarct Size and Left Ventricle Function after Acute Myocardial Infarction in Long-Term Follow-Up
por: Kleczyński, Paweł, et al.
Publicado: (2013)

Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control
por: Hsu, Chiao-Po, et al.
Publicado: (2014)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study
por: Czestkowska, Ewa, et al.
Publicado: (2019)

Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty
por: Derkacz, Arkadiusz, et al.
Publicado: (2011)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
por: Sibal, Latika, et al.
Publicado: (2009)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

Plasma asymmetric dimethylarginine is associated with vulnerable plaque and long-term outcomes in stable coronary artery disease
por: Huang, Shao-Sung, et al.
Publicado: (2023)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Live and let die: asymmetric dimethylarginine and septic shock
por: Böger, Rainer H
Publicado: (2006)

Mechanism of Cellular Oxidation Stress Induced by Asymmetric Dimethylarginine
por: Mohan, Srinidi, et al.
Publicado: (2012)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Asymmetric and symmetric dimethylarginines: metabolism and role in severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)

The Biological Axis of Protein Arginine Methylation and Asymmetric Dimethylarginine
por: Fulton, Melody D., et al.
Publicado: (2019)

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
por: Czarnecka, Anna, et al.
Publicado: (2016)

Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Erre, Gian Luca, et al.
Publicado: (2019)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
por: Atıcı, Adem, et al.
Publicado: (2019)

Cadmium-induced endothelial dysfunction mediated by asymmetric dimethylarginine
por: Al-Naemi, Hamda A., et al.
Publicado: (2020)

Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
por: Hannemann, Juliane, et al.
Publicado: (2020)

Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study
por: Chyrchel, Bernadeta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lig1b7e6jagu924872m2moct9r